Nearly 1 in 4 US workers say they are staying in a job they do not want for the health insurance, according to a survey.

Women with polyendocrine metabolic ovarian syndrome (PMOS), previously polycystic ovarian syndrome, have a higher incidence of ASCVD events.

Social prescribing, which connects people with arts and other support, may help adolescents waiting for specialist mental health services.

Topline phase 3 TRIUMPH-2 and TRIUMPH-3 trial data show robust weight loss and improved glycemic control with retatrutide in adults with T2D, obesity, and CVD.

As the aging population grows, a need increases for NPs to screen for common geriatric syndromes during routine primary care ...

The FDA has accepted Camurus' resubmitted NDA for CAM2029 (octreotide) extended-release injection for acromegaly, setting a PDUFA date of December 18, 2026.

Millions of people are breathing dangerous air this week as heavy smoke from wildfires in Canada and Minnesota spreads across the region.

The ACC has issued a 2026 scientific statement on the use of direct oral anticoagulants (DOACs) for the prevention of thrombotic events.

Prepregnancy obesity was associated with increased risk for preeclampsia and eclampsia, but the magnitude of this risk varies significantly across racial and ethnic groups.

Sleeve gastrectomy may offer greater weight loss and glycemic control than semaglutide or tirzepatide in adults with obesity and T2D.

Higher levels of interleukin (IL)-6 are associated with risk for 9 cardiovascular (CV) and mortality outcomes.

Tight control of disease activity and reduced glucocorticoid use delay the loss of muscle mass in women with rheumatoid arthritis.